Skip to main content
. 2021 Jan 28;11:543528. doi: 10.3389/fgene.2020.543528

Table 4.

Clinical characteristics of four patients having a variant of additional candidate genes.

No. Sex Age Onset time Proportion Genetic variants Neurocognitive function Dysmorphic face Accompanying anomalies Epilepsy Other features Disorder
Gene Inheritance Zygosity De novo Refseq Nucleotide Amino acid change 2015 ACMG
M-001 F 11m PM P JARID2 AD Het + NM_004973.3 c.2123A>C p.(Tyr708Ser) VUS Uncheckable Vague Holoprosen-cephaly IS → LGS None Epileptic encephalopathy
M-100 M 5y11m PM P RFX7 AD Het + NM_022841.6 c.2727_2730dup p.(Gly911PhefsTer58) VUS Uncheckable Vague None None None Intellectual disability
M-118 M 4y4m PM DP LMNB1 AD Het + NM_005573.3 c.1091T>C p.(Leu364Pro) VUS Uncheckable Vague Subependymal heterotopia LGS None Epileptic encephalopathy
M-122 M 1y5m PM P HPRT1 XLD Hemi NM_000194.3 c.151C>T p.(Arg51Ter) VUS Uncheckable Vague Valgus of ankle None Café au lait spot Neurofibro-matosis

2015 ACMG, 2015 American College of Medical Genetics and Genomics and Association for Molecular Pathology guideline; AD, autosomal dominant; DP, disproportionate; Hemi, hemizygous; Het, heterozygous; IS, infantile spasms; LGS, Lennox-Gastuat syndrome; P, proportionate; PM, primary microcephaly; SQ, social quotient; VUS, variant of uncertain significance; XLD, X-linked dominant.